Aldeyra Therapeutics (ALDX) FY Conference Transcript

Aldeyra Therapeutics (ALDX) FY Conference August 13, 2025 10:30 AM ET Speaker0Welcome everyone to HC Wainwright's fifth annual ophthalmology conference. My name is Matthew Caulfield, and I'm a senior biotech analyst here at HC Wainwright. We are grateful to welcome doctor Todd Brady, president and CEO of Ultera Therapeutics. Thank you very much, Todd, for joining us this morning. My pleasure.As always.Speaker1Thanks for having us.Speaker0Absolutely. So to start things off, Todd, maybe you could give us kind ...